Literature DB >> 19465366

Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.

Aaref Badshah1, Bakhtiar Mirza, Muhammad Janjua, Rajiv Nair, Russell T Steinman, John F Cotant.   

Abstract

Amiodarone is generally regarded to have a high safety profile with a low incidence of arrhythmias. However, there have been reports of torsades de pointes under certain conditions, such as electrolyte imbalance or concomitant antiarrhythmic therapy. We describe a case of amiodarone-induced torsade de pointes early after initiation of intravenous amiodarone in the setting of T-wave alternans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465366

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  2 in total

1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

2.  Torsade de Pointes and Persistent QTc Prolongation after Intravenous Amiodarone.

Authors:  Anna P Kotsia; Georgios Dimitriadis; Giannis G Baltogiannis; Theofilos M Kolettis
Journal:  Case Rep Med       Date:  2012-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.